Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis

Gut

Volumn 39, Issue 3, 1996, Pages 407-415

  Millar, A D ^a,c   Rampton, D S ^a   Chander, C L ^a   Claxson, A W D ^a   Blades, S ^a   Coumbe, A ^a   Panetta, J ^b   Morris, C J ^a   Blake, D R ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c Gastrointestinal Research Unit   (United Kingdom)

Author keywords

Acetic acid; Aminosalicylates; Antioxidant; Free radicals; Superoxide dismutase; Ulcerative colitis

Indexed keywords

2,6 DI TERT BUTYL 4 [(ETHYLAMINO)METHYL]PHENOL; ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DIMETHYL SULFOXIDE; HYDROCORTISONE; MESALAZINE; NEW DRUG; SODIUM AZIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENTEROCOLITIS; HISTOPATHOLOGY; INTESTINE BIOPSY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029842802     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.3.407     Document Type: Article

References (62)

1. Simmonds NJ, Allen RE, Stevens TRJ, van Someren RNM, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive metabolities in inflammatory bowel disease. Gastroenterology 1992; 103: 186-96.
2. Sedghi S, Fields JZ, Klamut M, et al. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 1993; 34: 1191-7.
3. Babbs CF. Oxygen radicals in ulcerative colitis. Free Rad Biol Med 1992; 13: 169-82.
4. Grisham MB, Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-61.
5. Repine JE, Eaton JW, Anders MW, Hoidal JR, Fox RB. Generation of hydroxyl radical by enzymes, chemicals and human phagocytes in vitro. Detection with the anti-inflammatory agent dimethyl sulphoxide. J Clin Invest 1979; 64: 1642-51.
6. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988; 33 (suppl): 6-15S.
7. Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology 1985; 89: 1162-82.
8. Grisham MB, MacDermott RP, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990; 14: 669-80.
9. Aruoma OI, Kaur H, Halliwell B. Oxygen free radicals and human diseases. J Roy Soc Health 1991; 111: 172-7.
10. Chakraborti S, Gunner GH, Michael JR. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. Am J Physiol 1989; 257: L430-7.
11. Reindeau D, Denis D, Choo LY, Nathaniel DJ. Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation. Biochem J 1989; 263: 565-72.
12. Zimmerman BJ, Grisham MB, Granger DN. Role of oxidants in ischaemia/reperfusion-induced granulocyte infiltration. Am J Physiol 1990; 258: G185-G90.
13. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of NFkappaB transcription factor and HIV-1. EMBO J 1991; 10: 2247-58.
14. Amstad PA, Krupitza G, Cerutti PA. Mechanism of c-fos induction by active oxygen. Cancer Res 1992; 52: 3952-60.
15. Ahnfelt-Ronne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990; 98: 1162-9.
16. Baltch AL, Hammer MC, Smith RP, et al. Comparison of the effect of three adrenal corticosteroids on human granulocyte function against Pseudomonas aeruginosa. J Trauma 1986; 26: 523-33.
17. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A. Phase II trial of superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun 1991; 12-13 (Pt 2): 563-9.
18. Levin KE, Pemberton JH, Phillips SF, Zinsmeister AR, Pezim ME. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum 1992; 35: 452-6.
19. Keshavarzian A, Sedghi S, Kanofsky J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992; 103: 177-85.
20. Yoshikawa T, Takahashi S, Kondo M. Possible role of free radicals in chronic inflammation in the gut. EXS 1992; 62: 353-8.
21. Sharon P, Stenson WF. Metabolism of arachonic acid in acetic acid. Similarity to human inflammatory bowel disease. Gastroenterology 1985; 88: 55-63.
22. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 1990; 31: 786-90.
23. Keshavarzian A, Haydek J, Zabihi R, Doria M, D'Astice M, Sorensen JRJ. Agents capable of eliminating reactive oxygen species: catalase, WR-2721, Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci 1992; 37: 1866-73.
24. Simmonds NJ. Reactive oxygen metabolites and inflammatory bowel disease [Doctor of Medicine, Thesis]. Oxford: 1992.
25. Simmonds NJ, Blake DR, Rampton DS. The effects of aminosalicylates and potential new drugs on mucosal reactive oxygen metabolite production in ulcerative colitis. Gut 1992; 33 (suppl): S7.
26. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135-50.
27. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
28. Allen RC. Phagocyte oxygenation activities: quantitative analysis based on chemiluminescence. In: Scholmerich J, Andreeson R, Knapp A, Ernst M, Woods WG, eds. Bioluminescence and chemiluminescence. New York: Wiley, 1986: 13-22.
29. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. (2nd ed.) Oxford: Clarendon, 1989.
30. Heikkila R. Inactivation of superoxide dismutase by diethylcarbamate. In: Greenwald R, ed. CRC handbook of methods for oxygen radical research. Boca Raton, Florida: CRC Press, 1985: 387-90.
31. Snedecor GW. Statistical methods applied to agriculture and biology. 5th ed. Iowa, USA: The Iowa State University Press, 1956: 62.
32. Staerk-Laursen L, Stokholm M, Bukhave K, Rask-Madsen J, Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut 1990; 31: 1271-6.
33. Maridonneau-Parini I, Errasfa M, Russo-Marie F. Inhibition of O2-generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest 1989; 83: 1936-40.
34. Nurcombe HL, Edwards SW. Role of myeloperoxidase in intracellular and extracellular chemiluminescence of neutrophils. Ann Rheum Dis 1989; 48: 56-62.
35. Hallett MB, Campbell AK. Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear phagocytes. Biochem J 1983; 216: 459-65.
36. McCord JM. Oxygen-derived free radicals in postischaemic tissue injury. N Engl J Med 1985; 312: 159-63.
37. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; ii: 1057-62.
38. Oshitani N, Kitano A, Okabe H, Nakamura S, Matsumoto T, Kobayashi K. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993; 34: 936-8.
39. Mulder TP, Verspaget HW, Janssens AR, deBruin PA, Pena AS, Lamers CB. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991; 32: 1146-50.
40. Niwa Y, Somiay K, Michelson AM, Puget K. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related disorders. Free Radic Res Commun 1985; 1: 137-53.
41. Gorecki M, Beck Y, Hartman JR, et al. Recombinant human superoxide dismutates: production and potential therapeutical uses. Free Radic Res Commun 1991; 12-13 Pt 1: 401-10.
42. Parizada B, Weber MM, Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991; 15: 297-301.
43. Susuki M, Grisham MB, Granger DN. Leukocyte-endothelial adhesive interactions: role of xanthine oxidase-derived oxidants. J Leukoc Biol 1991; 50: 488-94.
44. Bilota JJ, Wayne JD. Hydrogen peroxide enteritis: the "snow white" sign. Gastrointest Endosc 1989; 35: 428-30.
45. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad Biol Med 1989; 6: 593-7.
46. Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem Biophvs Res Commun 1975; 63: 463-8.
47. Halliwell B, Wasil M, Grootveld M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. FEBS Letts 1987; 213: 15-8.
48. Pettit SH, Shaffer JL, Johns CW, Bennett RJM, Irving MH. Ascorbic acid absorption in Crohn's disease. Studies using L-[carbonyl-14C] ascorbic acid. Dig Dis Sci 1989; 34: 559-60.
49. Fernandez-Banares F, Mingorance MD, Esteve M. Essential antioxidants in active idiopathic colitis. In Goebell H, Ewe K, Malchov H, Koebel C, eds. Inflammatory bowel disease. Progress in basic research and clinical implications. Lancaster: Kluwer Academic, 1991: 404.
50. Rowley DA, Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide and iron salts by superoxide- and ascorbate dependent mechanisms: relevance to the pathology of rheumatoid disease. Clin Sci 1983; 64: 649-53.
51. Clemens JA, Saunders RD, Ho PP, Phebus LA, Panetta JA. The antioxidant LY231617 reduces global ischaemic neuronal injury in rats. Stroke 1993; 24: 722-3.
52. Phillis JW, Sen S, Cao X. Amflutizole, a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/ reperfused rat cerebral cortex. Neurosci Letts 1994; 169: 188-90.
53. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathologv 1992; 21: 172-33.
54. Sharanov BP, Govorova NJ, Lyzlova SN. Serum protein degradation by hypochlorite. Biochem Int 1989; 19: 27-35.
55. Kjebanoff S. Oxygen metabolites from phagocytes. In: Gallin J, Goldstein I, Snyderman R, eds. New York: Raven Press, 1992: 541-88.
56. Dallegri F, Ottonello L, Ballestrero F, Ferrando F, Patrone F. Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylate in ulcerative colitis. Gut 1990; 31: 184-6.
57. Green TR, Fellman JH, Eicher AL, Pratt KL. Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophvs Acta 1991; 1073: 91-7.
58. Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulphoxide on the oxidative function of human neutrophils. J Lab Clin Med 1987; 110: 91-6.
59. Miyachi Y, Yashioka A, Imamura S, Niwa Y. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987, 28: 190-5.
60. Craven PA, Pfanstiel J, Saito R, DeRubertis FR. Actions of sulphasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid induced increases in colonic epithelial loss and proliferative activity. Gastroenterology 1987; 92: 1998-2008.
61. Aruoma OI, Wasil M, Halliwell B, Hoey BM, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 1987; 36: 3739-42.
62. Grisham MB. Effect of 5-aminosalicylic acid in ferrous sulphate-mediated damage to deoxyribose. Biochem Pharmacol 1990; 39: 2060-3.